Investigación y desarrollo en biotecnología: Opciones normativas para garantizar acceso y beneficios para los pobres
No hay miniatura disponible
Fecha
Autores
Título de la revista
ISSN de la revista
Título del volumen
Editor
Resumen
Descripción
The majority of biotech research and almost all of the commercialization of genetically engineered crops has been done by private firms based in industrialized countries. The dominance of the private sector in biotechnology research and product development has raised concern in developing countries that their farmers – particularly poor farmers – may not benefit from biotechnology either because it is not available or is too expensive. This paper examines the consequences of the emergence of a f ew large companies as the leaders in the commercialization of biotechnology and analyses a number of concerns about who benefits from biotech research. It reviews the status of crop biotechnology research worldwide and analyses the influence of intellectual property rights and market concentration on the development and diffusion of new technology. The paper explores the potential of public-private partnerships recommends policy measures and investments that could focus more biotechnology resear ch on the problems of the poor and alleviate some of the concerns about the impacts of biotechnology.